
NEW YORK (Reuters Health), Mar 26 - Some studies have suggested that moderate drinkers have a lower risk of developing rheumatoid arthritis, and now new findings link the habit to a slower progression of the joint disease.
In a study that followed 2,900 adults with rheumatoid arthritis (RA), Swiss researchers found that light-to-moderate drinkers showed slower progression in their joint damage compared with nondrinkers. Heavy drinkers, on the other hand, showed the greatest progression.
The findings, reported in the journal Arthritis & Rheumatism, are based on x-ray evidence of patients' joint damage and its progression over an average of four years.
The difference seen in moderate drinkers' and nondrinkers' progression was not substantial enough to be apparent in daily life -- that is, worse symptoms or more disability in the nondrinkers, according to Dr. Axel Finckh, of University Hospital of Geneva, one of the researchers on the study.
However, he told Reuters Health in an e-mail, if the slower progression were maintained over decades, it could become important.
The findings are in line with past research linking moderate drinking to a lower risk of developing RA, according to Finckh and his colleagues.
There is also animal research suggesting that alcohol may inhibit arthritis, possibly by reducing inflammation. Heavy drinking, on the other hand, seems to promote inflammation.
However, whether moderate drinking itself slows RA progression is not certain. More studies are needed to confirm the current findings, Finckh said, and even then, RA patients would not be advised to take up drinking.
Finckh pointed to the example of heart disease, where many studies have suggested a protective effect of moderate drinking, but -- owing to the potential risks of drinking -- experts do not advise people to start drinking for the sake of their hearts.
The current findings are based on 2,908 Swiss adults who were part of a national database on RA patients. All had had at least two sets of x-rays of their hands and feet over time, and had been followed for four years, on average.
Overall, 37% said they were nondrinkers at the outset, while the rest drank at least occasionally. The researchers found that both occasional drinkers and those who drank once per day generally had less joint damage progression over time than nondrinkers.
Study patients' drinking habits remained linked to RA progression when the researchers accounted for a number of other factors, including age, RA medication use, smoking, and the length of time each patient had had the disease.
The relationship between drinking and joint damage progression was stronger among men than women, however.
That sex difference was unexpected, according to Finckh and his colleagues, and the reasons for it are not clear. One possibility, they note, is the overall difference in alcohol "dose" between men and women; 27% of men said they drank once per day, versus only 14% of women.
The findings, according to the researchers, suggest that if people with RA already drink moderately, they should not be encouraged to stop.
"Further research is however required to better understand the impact of alcohol consumption on RA," they add.
By Amy Norton
Source: Arthritis & Rheumatism, online March 8, 2010.
Last Updated: 2010-03-25 10:04:57 -0400 (Reuters Health)
Related Reading
Ultrasound guidance does not improve benefit of joint injections for arthritis, March 19, 2010
Ultrasound detects subclinical synovitis in juvenile arthritis, November 27, 2009
Ultrasound densitometry finds beer helps women keep strong bones, September 23, 2009
Copyright © 2010 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.








![Overview of the study design. (A) The fully automated deep learning framework was developed to estimate body composition (BC) (defined as subcutaneous adipose tissue [SAT] in liters; visceral adipose tissue [VAT] in liters; skeletal muscle [SM] in liters; SM fat fraction [SMFF] as a percentage; and intramuscular adipose tissue [IMAT] in deciliters) from MRI. The fully automated framework comprised one model (model 1) to quantify different BC measures (SAT, VAT, SM, SMFF, and IMAT) as three-dimensional (3D) measures from whole-body MRI scans. The second model (model 2) was trained to identify standardized anatomic landmarks along the craniocaudal body axis (z coordinate field), which allowed for subdividing the whole-body measures into different subregions typically examined on clinical routine MRI scans (chest, abdomen, and pelvis). (B) BC was quantified from whole-body MRI in over 66,000 individuals from two large population-based cohort studies, the UK Biobank (UKB) (36,317 individuals) and the German National Cohort (NAKO) (30,291 individuals). Bar graphs show age distribution by sex and cohort. BMI = body mass index. (C) After the performance assessment of the fully automated framework, the change in BC measures, distributions, and profiles across age decades were investigated. Age-, sex-, and height-adjusted body composition reference curves were calculated and made publicly available in a web-based z-score calculator (https://circ-ml.github.io).](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/05/body-comp.XgAjTfPj1W.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)






